Ropinirole Extended-Release Tablets and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Ropinirole Extended-Release Tablets and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ropinirole
Brand name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit
Synonyms: Ropinirole, ROPINIRole
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ropinirole Extended-Release Tablets-Zoladex 3-Month
- Ropinirole Extended-Release Tablets-Zoladex Implant
- Ropinirole Extended-Release Tablets-Zolate
- Ropinirole Extended-Release Tablets-Zoledronic acid
- Ropinirole Extended-Release Tablets-Zoledronic Acid (Bone Health)
- Ropinirole Extended-Release Tablets-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Ropinirole Hydrochloride
- Zoladex (Goserelin Implant 3.6 mg)-Ropinirole Tablets
- Zoladex (Goserelin Implant 3.6 mg)-Ropivacaine
- Zoladex (Goserelin Implant 3.6 mg)-Ropivacaine Hydrochloride
- Zoladex (Goserelin Implant 3.6 mg)-Ropivacaine Injection
- Zoladex (Goserelin Implant 3.6 mg)-Rosac